Optimizing antidiabetic therapy: Enhancing COVID-19 outcomes for patients with type-2 diabetes

Chia Siang Kow; Dinesh Sangarran Ramachandram; Syed Shahzad Hasan

doi:10.1016/j.ando.2023.09.004

Optimizing antidiabetic therapy: Enhancing COVID-19 outcomes for patients with type-2 diabetes

Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	792
Number of pages	1
Journal	Annales d'Endocrinologie
Volume	84
Issue number	6
DOIs	https://doi.org/10.1016/j.ando.2023.09.004
Publication status	Published - 1 Dec 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ando.2023.09.004Licence: Unspecified

Cite this

@article{39f7ca233eb54d46883647ad6501ee5d,

title = "Optimizing antidiabetic therapy: Enhancing COVID-19 outcomes for patients with type-2 diabetes",

keywords = "COVID-19, Diabetes, Antidiabetic",

author = "Kow, {Chia Siang} and Ramachandram, {Dinesh Sangarran} and Hasan, {Syed Shahzad}",

year = "2023",

month = dec,

day = "1",

doi = "10.1016/j.ando.2023.09.004",

language = "English",

volume = "84",

pages = "792",

journal = "Annales d'Endocrinologie",

issn = "0003-4266",

publisher = "Elsevier Masson",

number = "6",

}

TY - JOUR

T1 - Optimizing antidiabetic therapy

T2 - Enhancing COVID-19 outcomes for patients with type-2 diabetes

AU - Kow, Chia Siang

AU - Ramachandram, Dinesh Sangarran

AU - Hasan, Syed Shahzad

PY - 2023/12/1

Y1 - 2023/12/1

KW - COVID-19

KW - Diabetes

KW - Antidiabetic

UR - http://www.scopus.com/inward/record.url?scp=85176736658&partnerID=8YFLogxK

U2 - 10.1016/j.ando.2023.09.004

DO - 10.1016/j.ando.2023.09.004

M3 - Letter

VL - 84

SP - 792

JO - Annales d'Endocrinologie

JF - Annales d'Endocrinologie

SN - 0003-4266

IS - 6

ER -

Optimizing antidiabetic therapy: Enhancing COVID-19 outcomes for patients with type-2 diabetes

UN SDGs

Access to Document

Other files and links

Cite this